Rainbow Medical
Zyvex Labs
With support from the BIRD Foundation, Rainbow Medical Ltd. (Israel) and Zyvex Labs Inc. (Richrdson, TX), developed the Bio-Retina, a “bionic retina” designed to replace the damaged retina in the eye and return full sight to those blinded by retinal degenerative conditions.
This tiny implant mimics the human eye’s natural physiological processes and is powered by a special pair of activation eyeglasses.
Nano Retina, a joint venture of Zyvex Labs and Rainbow Medical, is developed a bionic retina to restore sight to those suffering from retinal degenerative diseases.
On March 30, 2020, Nano Retina Ltd. reported preliminary results for First-in-Human implantations of its artificial retina devices. The first two patients, blinded by retinitis pigmentosa, have undergone the minimally invasive procedure to implant the device. Following activation of the device, both patients reported visual effects, which Nano Retina expects to optimize over the coming months allowing them to complete the clinical trial and bring this technology to market.
Nano Retina develops bionic retina for visually impaired (pdf)
BIRD ref 1263. Approved Dec. 2009